Observational Study of Dental Outcomes in Head and Neck Cancer Patients
Status: | Active, not recruiting |
---|---|
Conditions: | Cancer, Cancer, Other Indications, Dental |
Therapuetic Areas: | Dental / Maxillofacial Surgery, Oncology, Other |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 7/25/2018 |
Start Date: | February 2014 |
End Date: | November 2020 |
Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients
The purpose of this study is to measure the two-year rate of tooth loss in patients who have
received external beam radiation therapy with curative intent for head and neck cancer. The
study will also evaluate the sequelae of radiation therapy and oral complications that may
occur as a result to receiving radiation therapy.
received external beam radiation therapy with curative intent for head and neck cancer. The
study will also evaluate the sequelae of radiation therapy and oral complications that may
occur as a result to receiving radiation therapy.
This is a prospective cohort study to document dental and other oral outcomes in patients who
receive external beam radiation therapy with curative intent, as part of clinical care for a
head and neck cancer. Five hundred and seventy-five participants will be enrolled. All study
participants will receive a baseline oral examination prior to the start of radiation
therapy. Follow-up examinations and data collection will be conducted at six-month intervals
up to 2 years after the start of radiation therapy. The primary outcome will be the two-year
rate of tooth loss. Secondary outcomes will include measures of dental caries, periodontal
health, salivary flow, and exposed bone/osteoradionecrosis.
The proposed research will provide more information to inform the community about the
sequelae of Radiation Therapy (RT) in head and neck cancer patients, to refine current
guidelines and to design future studies on the dental management of these patients.
receive external beam radiation therapy with curative intent, as part of clinical care for a
head and neck cancer. Five hundred and seventy-five participants will be enrolled. All study
participants will receive a baseline oral examination prior to the start of radiation
therapy. Follow-up examinations and data collection will be conducted at six-month intervals
up to 2 years after the start of radiation therapy. The primary outcome will be the two-year
rate of tooth loss. Secondary outcomes will include measures of dental caries, periodontal
health, salivary flow, and exposed bone/osteoradionecrosis.
The proposed research will provide more information to inform the community about the
sequelae of Radiation Therapy (RT) in head and neck cancer patients, to refine current
guidelines and to design future studies on the dental management of these patients.
Inclusion Criteria:
- Aged 18 years and older;
- Willing and able to provide signed and dated consent form;
- Diagnosed with head and neck squamous cell carcinoma (SCC) or a salivary gland cancer
(SGC), and intends to receive external beam radiation therapy (RT) with curative
intent (tumor eradication), with or without concomitant chemotherapy;
OR
- Diagnosed with a non-SCC, non-SGC malignancy of the head and neck region, and intends
to receive RT, with or without concomitant chemotherapy. The subject must be expected
to receive at least 4500 cGy to one of the following sites:
1. base of tongue
2. buccal/labial mucosa
3. epiglottis
4. floor of mouth
5. gingiva/alveolar ridge
6. hard palate
7. hypopharynx
8. larynx
9. lip
10. mandible
11. maxilla
12. maxillary sinus
13. nasal cavity
14. nasopharynx
15. neck
16. oral cavity
17. oral tongue
18. oropharynx
19. paranasal sinus/orbit
20. parotid gland
21. pharynx
22. retromolar trigone
23. soft palate
24. sublingual gland
25. submandibular gland
26. tonsil;
- At least 1 natural tooth remaining or expected to remain in the mouth after completion
of the pre-RT dental extractions, if any;
- Willing to comply with all study procedures;
- Willing to participate for the duration of the study.
Exclusion Criteria:
- Receiving palliative RT;
- History of prior curative RT to the head and neck region to eradicate a malignancy;
- Incarcerated at time of screening;
- Anything that would place the subject at increased risk or preclude the subject's full
compliance with or completion of the study.
We found this trial at
6
sites
75 Francis street
Boston, Massachusetts 02115
Boston, Massachusetts 02115
(617) 732-5500
Principal Investigator: Nathaniel Treister, DMD
Phone: 617-732-6813
Brigham and Women's Hosp Boston’s Brigham and Women’s Hospital (BWH) is an international leader in...
Click here to add this to my saved trials
Chapel Hill, North Carolina 27599
Principal Investigator: Lauren Patton, DDS
Phone: 919-537-3361
Click here to add this to my saved trials
Charlotte, North Carolina 28203
Principal Investigator: Michael Brennan, DDS, MHS
Phone: 704-355-0174
Click here to add this to my saved trials
Farmington, Connecticut 06030
Principal Investigator: Rajesh Lalla, DDS, PhD
Phone: 860-679-3918
Click here to add this to my saved trials
New York, New York 10019
Principal Investigator: Brian Schmidt, DDS, MD, PhD
Phone: 212-998-9202
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19104
Principal Investigator: Thomas Sollecito, DDS
Phone: 215-349-5409
Click here to add this to my saved trials